NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/11/2024
Voltar para busca
Dado oficial do USPTO
VITALANT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000087907306Classe
35, 36, 39, 40, 41, 42, 44
Pedido
87907306
Registro
5729705
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
04/11/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
35, 36, 39, 40, 41, 42, 44
Data de depósito
04/05/2018
Data de registro
16/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/11/2024
Última transação
04/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
24/09/2018
Primeiro uso no comércio
24/09/2018
Código do desenho
3
Tipo de titular
03
Localização do titular
Scottsdale, AZ
Examinador
CHADAB, SETH
Localização atual
Historical data usage
Descrição da marca
The mark consists of the word "VITALANT" followed by butterfly wings.
Titulares e representantes
Titulares
VITALANT
Blood Systems, Inc.
Representantes
Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 39Classe 40Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Inventory management in the field of biologic and specialty pharmaceutical products in the nature of therapeutic plasma-derivatives and recombinant coagulation products provided to hospitalsclinicshome care companieshemophilia and thrombosis centersphysician offices; promoting public awareness of the need for blood donorspublic awareness about blood products and community blood bank centers; arranging procurement of goods for others in the field of human bonetissueorgans for purposes of transplantation; and distributorship services in the field of human blood and blood productstherapeutic plasma-derivatives and recombinant coagulation products
Classe 36
Charitable fundraising services in the field of human blood and blood products to support blood bank operations and research in the field of transfusion medicine
Classe 39
Storage of human bonetissueorgans for purposes of transplantation
Classe 40
Processing of human bonetissueorgans for purposes of transplantation
Classe 41
Educational servicesproviding educational materials to the general public and health care professionals about blood donation and transfusion; providing training and continuing professional education courses in the field of healthsafetymedicineimmunologyblood bankingtransfusion and human resources and business management in the transfusion medicine and blood banking laboratory fields
Classe 42
Laboratoryclinical and translational research in the field of transfusion medicineinfectious disease; blood analysis services; medical blood laboratory services; medical research in the field of blood; and providing quality assurance services in the field of blood and blood products
Classe 44
Blood bank servicescollectionsupplypreservationdistributioncoordination of human blood and blood products; organ and tissue bank services; medical testing of blood; blood bank servicesprocessing of blood
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/11/2024
E815
TEAS SECTION 8 & 15 RECEIVED
14/05/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
16/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/07/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/07/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/07/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/07/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
13/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
16/04/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/03/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/03/2019
DOCK
ASSIGNED TO EXAMINER
07/03/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/01/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/01/2019
IUAF
USE AMENDMENT FILED
20/12/2018
EISU
TEAS STATEMENT OF USE RECEIVED
20/12/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
20/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/09/2018
PUBO
PUBLISHED FOR OPPOSITION
25/09/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/09/2018
ALIE
ASSIGNED TO LIE
21/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/08/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/08/2018
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
19/07/2018
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
19/07/2018
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
19/07/2018
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
19/07/2018
DOCK
ASSIGNED TO EXAMINER
12/07/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
15/05/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/05/2018
NWAP
NEW APPLICATION ENTERED
08/05/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VITALANT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.